Jean-Marc Roelandt

Jean-Marc Roelandt is a Senior executive with an established track record of more than 25 years as Chief Financial Officer in globally active publicly listed companies.

With a focus on M&A, capital market transactions and the implementation of adequate financial management infrastructure in dynamic and fast growing companies, he built up a solid expertise in various industries. Prior to joining Biocartis, he was Chief Financial Officer of MDxHealth, a multinational healthcare company that provides actionable genomic information to personalize the diagnosis and treatment of cancer.

Jean-Marc Roelandt holds a master’s Degree in Applied Economics from the University of Ghent (Belgium).